Corgenix periodically draws on the expertise of advisors and consultants in fields related to its technology and markets. These members are available to Corgenix as needed on an individual basis to provide advice with respect to clinical medicine and other matters requiring scientific expertise. Non-employee members of the scientific advisory board are compensated for their participation.
About Corgenix Medical Corporation
Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 50 diagnostic products through a global distribution network. More information is available at http://www.corgenix.com.
Statements in this press release that are not strictly historical facts
are "forward-looking" statements (identified by the words "believe",
"estimate", "project", "expect" or similar expressions) within the meaning
of the Private Securities Litigation Reform Act of 1995. These statements
inherently involve risks and uncertainties that could cause actual results
to differ materially from the forward-looking statements. Factors that
would cause or contribute to such differences include, but are not limited
to, continued acceptance of the Company's products and services in the
marketplace, competitive factors, changes in the regulatory environment,
and other risks detailed in the Company's periodic report filings with the
Securities and Exchange Commission. The statements in this press release
are made a
|SOURCE Corgenix Medical Corporation|
Copyright©2008 PR Newswire.
All rights reserved